{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:47:21Z","timestamp":1781088441580,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jns.2026.125852","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:22:48Z","timestamp":1772554968000},"page":"125852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis"],"prefix":"10.1016","volume":"484","author":[{"given":"Ahmed","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsayed","family":"Balbaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer","family":"Awashra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalhakim","family":"Shubietah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cavolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Villari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"And\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sabouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.125852_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1212\/WNL.0000000000002431","article-title":"Association of atrial fibrillation with mortality and disability after ischemic stroke","volume":"86","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125852_bb0010","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.0000000000003321","article-title":"Increasing atrial fibrillation prevalence in acute ischemic stroke and TIA","volume":"87","author":"Otite","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125852_bb0015","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2026.125852_bb0020","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jns.2026.125852_bb0025","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur. Heart J."},{"issue":"855\u201363","key":"10.1016\/j.jns.2026.125852_bb0030","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"Goto","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jns.2026.125852_bb0035","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241240746","article-title":"The impact of atherosclerotic burden on vascular outcomes in patients with stroke and atrial fibrillation: the ATHENA study","volume":"30","author":"Rigutini","year":"2024","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.jns.2026.125852_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2025.3662","article-title":"Optimal antithrombotics for ischemic stroke and concurrent atrial fibrillation and atherosclerosis: a randomized clinical trial","author":"Okazaki","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2026.125852_bb0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/17474930231158211","article-title":"Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis","volume":"18","author":"Kim","year":"2023","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2026.125852_bb0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41598-023-51013-3","article-title":"Combined use of anticoagulant and antiplatelet on outcome after stroke in patients with nonvalvular atrial fibrillation and systemic atherosclerosis","volume":"14","author":"Heo","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.125852_bb0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2026.125852_bb0060","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2026.125852_bb0065","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2026.125852_bb0070","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v106.i02","article-title":"Netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jns.2026.125852_bb0075","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s12975-020-00822-z","article-title":"Effectiveness of adding Antiplatelets to Oral anticoagulants in patients with acute ischemic stroke with atrial fibrillation and concomitant large artery steno-occlusion","volume":"11","author":"Kim","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.jns.2026.125852_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000526896","article-title":"Safety of Apixaban monotherapy for non-Valvular atrial fibrillation-related acute stroke with intra\u2212\/Extracranial artery stenosis","volume":"52","author":"Koyanagi","year":"2023","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2026.125852_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123352","article-title":"Antithrombotic therapy for secondary stroke prevention in patients with symptomatic large artery atherosclerosis and atrial fibrillation (FIB-CAS study) a single-center experience","volume":"468","author":"Mohamed","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125852_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/NRL.0000000000000590","article-title":"Outcomes and antithrombotic regimens in Nonvalvular atrial fibrillation patients with acute ischemic stroke and competing large-artery atherosclerosis","volume":"30","author":"Xue","year":"2025","journal-title":"Neurologist"},{"key":"10.1016\/j.jns.2026.125852_bb0095","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1161\/STROKEAHA.114.006929","article-title":"Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation","volume":"45","author":"McGrath","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2026.125852_bb0100","article-title":"Antithrombotic agents and effect on outcomes in ischemic stroke with atrial fibrillation and large artery atherosclerosis: a real-world study","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.125852_bb0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12916-024-03338-7","article-title":"The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study","volume":"22","author":"Tsai","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.jns.2026.125852_bb0110","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1080\/14656566.2025.2610371","article-title":"Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysis","volume":"26","author":"Ibrahim","year":"2025","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jns.2026.125852_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: state-of-the-art and future directions","volume":"49","author":"Elsheikh","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.jns.2026.125852_bb0120","first-page":"10","article-title":"Diagnosis and management of atrial fibrillation in acute ischemic stroke in the setting of reperfusion therapy: insights and strategies for optimized care","author":"Patel","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.jns.2026.125852_bb0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacasi.2025.04.010","article-title":"Position statement on antiplatelet therapy for east asians with coronary artery disease: 2025 update","volume":"5","author":"Gong","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.jns.2026.125852_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3988\/jcn.2022.0289","article-title":"Stroke-specific predictors of major bleeding in anticoagulated patients with stroke and atrial fibrillation: a Nationwide Multicenter registry-based study","volume":"19","author":"Chung","year":"2023","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jns.2026.125852_bb0135","first-page":"26","article-title":"Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study","author":"Ahn","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.jns.2026.125852_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/17474930231210397","article-title":"Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability","volume":"19","author":"Downer","year":"2024","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2026.125852_bb0145","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"Chao","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.jns.2026.125852_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5853\/jos.2014.16.1.8","article-title":"Ischemic stroke subtype classification: an asian viewpoint","volume":"16","author":"Kim","year":"2014","journal-title":"J. Stroke"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:04:04Z","timestamp":1775786644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S0022510X26001346"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125852","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125852"}}